Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arata Azuma

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Immunopharmacology and Immunotoxicology|September 16, 2008
The effects of oxidative stress induced by prolonged low-dose diesel exhaust particle exposure on the generation of allergic airway inflammation differ between BALB/c and C57BL/6 miceYing-Ji Li, Hajime Takizawa, Arata Azuma, et al.
Journal of the American Geriatrics Society|September 9, 2008
Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysisMutsuo Yamaya, Arata Azuma, Hiroshi Tanaka, et al.
Advances in Therapy|January 24, 2023
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in JapanTakashi Ogura, Yoshikazu Inoue, Arata Azuma, et al.
Respiratory Medicine|August 13, 2019
Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanibLuca Richeldi, Bruno Crestani, Arata Azuma, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 21, 2016
Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysisNaoyuki Kuse, Shinji Abe, Hiroki Hayashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 9, 2007
[A case of secondary pulmonary cryptococcosis with pleural effusion involving type 1 allergy]Takahito Nei, Tatsuji Enomoto, Tetsu Sakamoto, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 1, 2006
[Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease]Masao Okumura, Kazuro Iwai, Hideo Ogata, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2006
Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosisYoshitsugu Seo, Shinji Abe, Misuzu Kurahara, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2010
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Clinical characteristics of biopsy-proven renal sarcoidosis in JapanYoshinori Kamata, Hiroshi Sato, Kensuke Joh, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Immunopharmacology and Immunotoxicology|September 16, 2008
The effects of oxidative stress induced by prolonged low-dose diesel exhaust particle exposure on the generation of allergic airway inflammation differ between BALB/c and C57BL/6 miceYing-Ji Li, Hajime Takizawa, Arata Azuma, et al.
Journal of the American Geriatrics Society|September 9, 2008
Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysisMutsuo Yamaya, Arata Azuma, Hiroshi Tanaka, et al.
Advances in Therapy|January 24, 2023
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in JapanTakashi Ogura, Yoshikazu Inoue, Arata Azuma, et al.
Respiratory Medicine|August 13, 2019
Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanibLuca Richeldi, Bruno Crestani, Arata Azuma, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 21, 2016
Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysisNaoyuki Kuse, Shinji Abe, Hiroki Hayashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 9, 2007
[A case of secondary pulmonary cryptococcosis with pleural effusion involving type 1 allergy]Takahito Nei, Tatsuji Enomoto, Tetsu Sakamoto, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 1, 2006
[Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease]Masao Okumura, Kazuro Iwai, Hideo Ogata, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2006
Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosisYoshitsugu Seo, Shinji Abe, Misuzu Kurahara, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2010
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Clinical characteristics of biopsy-proven renal sarcoidosis in JapanYoshinori Kamata, Hiroshi Sato, Kensuke Joh, et al.
Pageof 23